Injured erythrocytes release adenosine deaminase into the circulation

EK Jackson, Z Mi, MT Koehler, JA Carcillo and WA Herzer

Department of Pharmacology, University of Pittsburgh Medical Center, Pennsylvania, USA.

The purpose of this study was to test the hypothesis that circulating red blood cells (RBCs) release adenosine deaminase (ADA) when injured. This hypothesis was evaluated in rats using dimethyl sulfoxide (DMSO) to damage RBCs. Boluses and infusions of DMSO caused a reduction in urinary adenosine and a concomitant hemoglobinuria, and the ability of DMSO to reduce urinary adenosine was blocked by pretreatment with the ADA inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine. Infusions of DMSO also significantly enhanced ADA activity in urine and plasma. Dimethylsulfone, an analog of DMSO that does not affect RBCs, did not cause hemoglobinuria and did not affect urinary adenosine. High concentrations of DMSO did not affect adenosine metabolism in rat kidneys perfused without RBCs, and DMSO did not decrease urinary adenosine in rats rendered severely anemic (hematocrit < 15%) by replacing whole blood with plasma. However, DMSO did decrease urinary adenosine in rats without a spleen, a major source of adenosine deaminase apart from circulating RBCs. DMSO reduced renal interstitial levels of adenosine and attenuated bradycardic responses to exogenous adenosine, and these effects were prevented by erythro-9-(2-hydroxy-3- nonyl)adenine. These results indicate that circulating damaged RBCs release significant amounts of ADA, a process that may predispose to vasoocclusive events.

Volume 279, Issue 3, pp. 1250-1260, 12/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J. Ren, Z. Mi, and E. K. Jackson Assessment of Nerve Stimulation-Induced Release of Purines from Mouse Kidneys by Tandem Mass Spectrometry J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 920 - 926. [Abstract] [Full Text] [PDF]

				E. K. Jackson and Z. Mi Regulation of Renal Ectophosphodiesterase by Protein Kinase C and Sodium Diet J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 210 - 216. [Abstract] [Full Text] [PDF]

				E. K. Jackson, Z. Mi, L. C. Zacharia, S. P. Tofovic, and R. K. Dubey The Pancreatohepatorenal cAMP-Adenosine Mechanism J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 799 - 809. [Abstract] [Full Text] [PDF]

				E. K. Jackson, Z. Mi, and R. K. Dubey The Extracellular cAMP-Adenosine Pathway Significantly Contributes to the in Vivo Production of Adenosine J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 117 - 123. [Abstract] [Full Text] [PDF]

				E. K. Jackson, L. C. Zacharia, M. Zhang, D. G. Gillespie, C. Zhu, and R. K. Dubey cAMP-Adenosine Pathway in the Proximal Tubule J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1219 - 1229. [Abstract] [Full Text] [PDF]

				T. Raskovalova, X. Huang, M. Sitkovsky, L. C. Zacharia, E. K. Jackson, and E. Gorelik Gs Protein-Coupled Adenosine Receptor Signaling and Lytic Function of Activated NK Cells J. Immunol., October 1, 2005; 175(7): 4383 - 4391. [Abstract] [Full Text] [PDF]

				E. K. Jackson, Z. Mi, C. Zhu, and R. K. Dubey Adenosine Biosynthesis in the Collecting Duct J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 888 - 896. [Abstract] [Full Text] [PDF]

				B. Cometti, R. K. Dubey, B. Imthurn, E. K. Jackson, and M. Rosselli Oviduct Cells Express the Cyclic AMP-Adenosine Pathway Biol Reprod, September 1, 2003; 69(3): 868 - 875. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Endogenous Cyclic AMP-Adenosine Pathway Regulates Cardiac Fibroblast Growth Hypertension, April 1, 2001; 37(4): 1095 - 1100. [Abstract] [Full Text] [PDF]

				E. K. Jackson and Z. Mi Preglomerular Microcirculation Expresses the cAMP-Adenosine Pathway J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 23 - 28. [Abstract] [Full Text]

				R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Cardiac Fibroblasts Express the cAMP-Adenosine Pathway Hypertension, September 1, 2000; 36(3): 337 - 342. [Abstract] [Full Text] [PDF]

				M. B. Forman, J. V. Vitola, C. E. Velasco, J. J. Murray, R. K. Dubey, and E. K. Jackson Sustained Reduction in Myocardial Reperfusion Injury with an Adenosine Receptor Antagonist: Possible Role of the Neutrophil Chemoattractant Response J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 929 - 938. [Abstract] [Full Text]

				R. K. Dubey, D. G. Gillespie, Z. Mi, M. Rosselli, P. J. Keller, and E. K. Jackson Estradiol Inhibits Smooth Muscle Cell Growth in Part by Activating the cAMP-Adenosine Pathway Hypertension, January 1, 2000; 35(1): 262 - 266. [Abstract] [Full Text] [PDF]

				E. K. Jackson, W. A. Herzer, Z. Mi, S. J. Vyas, and C. K. Kost Jr Low-Dose Angiotensin II Reduces Urinary Cyclic AMP Excretion in Spontaneously Hypertensive, But Not Normotensive, Rats: Independence from Hypertension and Renal Hemodynamic Effects of Angiotensin J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 115 - 123. [Abstract] [Full Text]

				T. Inoue, Z. Mi, D. G. Gillespie, R. K. Dubey, and E. K. Jackson Angiotensin Receptor Subtype 1 Mediates Angiotensin II Enhancement of Isoproterenol-Induced Cyclic AMP Production in Preglomerular Microvascular Smooth Muscle Cells J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1229 - 1234. [Abstract] [Full Text]

				R. Mokkapatti, S. J. Vyas, G. G. Romero, Z. Mi, T. Inoue, R. K. Dubey, D. G. Gillespie, A. K. Stout, and E. K. Jackson Modulation by Angiotensin II of Isoproterenol-Induced cAMP Production in Preglomerular Microvascular Smooth Muscle Cells from Normotensive and Genetically Hypertensive Rats J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 223 - 231. [Abstract] [Full Text]

				E. K. Jackson, Z. Mi, D. G. Gillespie, and R. K. Dubey Metabolism of cAMP to Adenosine in the Renal Vasculature J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 177 - 182. [Abstract] [Full Text]